Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 104 results.
User Information
Export Records
  1. 1.   In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4+ T-Cells
  2. Bissa, Massimiliano; Galli, Veronica; Schifanella, Luca; Vaccari, Monica; Rahman, Mohammad Arif; Gorini, Giacomo; Binello, Nicolò; Sarkis, Sarkis; Gutowska, Anna; Silva de Castro, Isabela; Doster, Melvin N; Moles, Ramona; Ferrari, Guido; Shen, Xiaoying; Tomaras, Georgia D; Montefiori, David C; N'guessan, Kombo F; Paquin-Proulx, Dominic; Kozlowski, Pamela A; Venzon, David J; Choo-Wosoba, Hyoyoung; Breed,Matthew; Kramer,Josh; Franchini, Genoveffa
  3. Vaccines. 2023, Oct 30; 11(11):
  1. 2.   Macrophage-mediated extracellular matrix remodeling controls host Staphylococcus aureus susceptibility in the skin
  2. Voisin, Benjamin; Nadella, Vinod; Doebel, Thomas; Goel, Shubham; Sakamoto, Keiko; Ayush, Otgonzaya; Jo, Jay-Hyun; Kelly,Michael; Kobayashi, Tetsuro; Jiang, Jean X; Hu, Ying; Yan, Chunhua; Nagao, Keisuke
  3. Immunity. 2023, Jul 11; 56(7): 1561-1577.e9.
  1. 3.   Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling
  2. Cecchi, Fabiola; Rex, Karen; Schmidt, Joanna; Vocke, Cathy D; Lee, Young H; Burkett, Sandra; Baker, Daniel; Damore, Michael A; Coxon, Angela; Burgess, Teresa L; Bottaro, Donald P
  3. Cancers. 2023, Jan 11; 15(2):
  1. 4.   Fgf8 promotes survival of nephron progenitors by regulating BAX/BAK-mediated apoptosis
  2. Anderson,Matthew; Misaghian, Salvia; Sharma,Nirmala; Perantoni,Alan; Lewandoski,Mark
  3. Differentiation; research in biological diversity. 2022, Dec 06; 130: 7-15.
  1. 5.   A molecular mechanism for the generation of ligand-dependent differential outputs by the epidermal growth factor receptor
  2. Huang, Yongjian; Ognjenovic,Jana; Karandur, Deepti; Miller, Kate; Merk,Alan; Subramaniam, Sriram; Kuriyan, John
  3. eLife. 2021, Nov 30; 10
  1. 6.   Inactivation of Fgf3 and Fgf4 within the Fgf3/Fgf4/Fgf15 gene cluster reveals their redundant requirement for mouse inner ear induction and embryonic survival
  2. Zelarayan, Laura; Vendrell, Victor; Domínguez-Frutos, Elena; López-Hernández, Iris; Schimmang-Alonso, Kiril; Alonso, María Teresa; Alvarez, Yolanda; Maier, Hannes; Anderson,Matthew; Lewandoski,Mark; Schimmang, Thomas
  3. Developmental dynamics : an official publication of the American Association of Anatomists. 2021, Nov 12;
  1. 7.   Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
  2. Hwang, Ilseon; Kim, Jeong Won; Ylaya, Kris; Chung, Eun Joo; Kitano, Haruhisa; Perry,Candice; Hanaoka, Jun; Fukuoka, Junya; Chung, Joon-Yong; Hewitt, Stephen M
  3. Journal of translational medicine. 2020, Nov 23; 18(1): 443.
  1. 8.   The Fgf8 subfamily (Fgf8, Fgf17 and Fgf18) is required for closure of the embryonic ventral body wall
  2. Boylan,Michael; Anderson,Matthew; Ornitz, David M; Lewandoski,Mark
  3. Development (Cambridge, England). 2020, NOV; 147(21): pii: dev.189506.
  1. 9.   Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
  2. Gillies, Taryn E; Pargett, Michael; Silva, Jillian M; Teragawa, Carolyn K; McCormick, Frank; Albeck, John G
  3. Molecular systems biology. 2020, Oct; 16(10): e9518.
  1. 10.   Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids
  2. Frias, Maria A.; Mukhopadhyay,Suman; Lehman, Elyssa; Walasek, Aleksandra; Utter, Matthew; Menon, Deepak; Foster, David A.
  3. JOURNAL OF BIOLOGICAL CHEMISTRY. 2020, JAN 3; 295(1): 263-274.
  1. 11.   A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cells
  2. Chen, Zhizhen; Liu, Jie; Chu, Dafeng; Shan, Yaming; Ma, Guixing; Zhang, Hongmin; Zhang, Xiaohua Douglas; Wang, Pu; Chen, Qiang; Deng, Chuxia; Chen, Weizao; Dimitrov, Dimiter S.; Zhao, Qi
  3. International Journal of Biological Sciences. 2018, May 21; 14(7): 799-806.
  1. 12.   The G-Protein-Coupled Chemoattractant Receptor Fpr2 Exacerbates High Glucose-Mediated Proinflammatory Responses of Müller Glial Cells
  2. Yu, Ying; Bao, Zhiyao; Wang, Xiaofei; Gong, Wang; Chen, Hui; Guan, Huaijin; Le, Yingying; Su, Shaobo; Chen, Keqiang; Wang, Jiming
  3. Frontiers in Immunology. 2017, Dec 19; 8: 1852.
  1. 13.   Transforming Growth Factor-ß (TGF-ß) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway.
  2. Tang, Liu-Ya; Heller, Mary; Meng, Zhaojing; Yu, Li-Rong; Tang, Yi; Zhou, Ming; Zhang, Ying E
  3. The Journal of biological chemistry. 2017, Mar 10; 292(10): 4302-4312.
  1. 14.   Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
  2. Chen, Teresa K; Choi, Michael J; Kao, W H Linda; Astor, Brad C; Scialla, Julia J; Appel, Lawrence J; Li, Liang; Lipkowitz, Michael S; Wolf, Myles; Parekh, Rulan S; Winkler, Cheryl; Estrella, Michelle M; Crews, Deidra C
  3. Clinical journal of the American Society of Nephrology : CJASN. 2015, Dec 7; 10(12): 2128-35.
  1. 15.   TrkA in vivo function is negatively regulated by ubiquitination
  2. Kiris, E.; Wang, T.; Yanpallewar, S.; Dorsey, S. G.; Becker, J.; Bavari, S.; Palko, M. E.; Coppola, V.; Tessarollo, L.
  3. Journal of Neuroscience. 2014, 12-Mar; 34(11): 4090-8.
  1. 16.   Transforming growth factor beta in cancer: Janus, the two-faced god
  2. Salomon, D.
  3. Journal of the National Cancer Institute. 2014, Feb; 106(2): djt441.
  1. 17.   Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296
  2. Langenkamp, E.; Zwiers, P. J.; Moorlag, H. E.; Leenders, W. P.; Croix, B. S.; Molema, G.
  3. Anti-Cancer Drugs. 2012, Feb; 23(2): 161-172.
  1. 18.   Dissecting the diverse functions of the metastasis suppressor CD82/KAI1
  2. Tsai, Y. C.; Weissman, A. M.
  3. Febs Letters. 2011, Oct; 585(20): 3166-3173.
  1. 19.   Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression
  2. Madlala, P.; Gijsbers, R.; Christ, F.; Hombrouck, A.; Werner, L.; Mlisana, K.; An, P.; Karim, S. S. A.; Winkler, C. A.; Debyser, Z.; Ndung'u, T.
  3. Aids. 2011, Sep; 25(14): 1711-1719.
  1. 20.   Peptide Structure Stabilization by Membrane Anchoring and its General Applicability to the Development of Potent Cell-Permeable Inhibitors
  2. Johannessen, L.; Remsberg, J.; Gaponenko, V.; Adams, K. M.; Barchi, J. J.; Tarasov, S. G.; Jiang, S.; Tarasova, N. I.
  3. Chembiochem. 2011, Apr; 12(6): 914-921.
  1. 21.   Lsh participates in DNA methylation and silencing of stem cell genes
  2. Xi, S.; Geiman, T. M.; Briones, V.; Guang Tao, Y.; Xu, H.; Muegge, K.
  3. Stem Cells. 2009, Nov; 27(11): 2691-702.
  1. 22.   Characterization of a chimeric monoclonal antibody against the insulin-like growth factor-I receptor
  2. Zhang, M. Y.; Feng, Y.; Wang, Y.; Dimitrov, D. S.
  3. Mabs. 2009, Sep-Oct; 1(5): 475-80.
  1. 23.   A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors
  2. Chen, J. H.; Yao, X. H.; Gong, W.; Hu, J.; Zhou, X. D.; Chen, K.; Liu, H.; Ping, Y. F.; Wang, J. M.; Bian, X. W.
  3. Journal of Neuro-Oncology. 2007, Sep; 84(3): 223-231.
  1. 24.   The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells
  2. Ping, Y. F.; Yao, X. H.; Chen, J. H.; Liu, H.; Chen, D. L.; Zhou, X. D.; Wang, J. M.; Bian, X. W.
  3. Journal of Neuro-Oncology. 2007, Aug; 84(1): 21-29.
  1. 25.   Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): Novel marker for cervical carcinogenesis
  2. Miyatake, T.; Ueda, Y.; Nakashima, R.; Yoshino, K.; Kimura, T.; Murata, T.; Nomura, T.; Fujita, M.; Buzard, G. S.; Enomoto, T.
  3. International Journal of Cancer. 2007, May; 120(10): 2068-2077.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel